Last reviewed · How we verify
Base Monotherapy
At a glance
| Generic name | Base Monotherapy |
|---|---|
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Base Monotherapy CI brief — competitive landscape report
- Base Monotherapy updates RSS · CI watch RSS
- Merck Sharp & Dohme LLC portfolio CI